Mika Kitagawa

564 total citations
29 papers, 410 citations indexed

About

Mika Kitagawa is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mika Kitagawa has authored 29 papers receiving a total of 410 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 12 papers in Surgery and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mika Kitagawa's work include Gastric Cancer Management and Outcomes (9 papers), Pancreatic and Hepatic Oncology Research (5 papers) and MicroRNA in disease regulation (4 papers). Mika Kitagawa is often cited by papers focused on Gastric Cancer Management and Outcomes (9 papers), Pancreatic and Hepatic Oncology Research (5 papers) and MicroRNA in disease regulation (4 papers). Mika Kitagawa collaborates with scholars based in Japan, United States and Greece. Mika Kitagawa's co-authors include Takaya Shimura, Hiromi Kataoka, Hiroyasu Iwasaki, Sadanobu Kagamimori, M Tsujimoto, Yusuke Okuda, Tamaki Yamada, Tomonori Yamada, Masahide Ebi and Shin‐ichi Horike and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and British Journal of Cancer.

In The Last Decade

Mika Kitagawa

25 papers receiving 403 citations

Peers

Mika Kitagawa

PRM

SURGE

ONCOL

Hai-Bo Qiu China

Ryota Otsuka Japan

Jingyu Zhu China

Miaozun Zhang China

Hirofumi Satake Japan

Yakun Wang China

Joanna Kiśluk Poland

Rodica Bîrlă Romania

Xiao‐Jiang Chen China

Chao Lin China

Hai-Bo Qiu China

Mika Kitagawa

120 ×0.6

PRM

133 ×1.0

87 ×0.8

SURGE

75 ×0.7

80 ×0.8

ONCOL

Citations per year, relative to Mika Kitagawa Mika Kitagawa (= 1×) peers Hai-Bo Qiu

Countries citing papers authored by Mika Kitagawa

Since Specialization

Citations

This map shows the geographic impact of Mika Kitagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Kitagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Kitagawa more than expected).

Fields of papers citing papers by Mika Kitagawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Kitagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Kitagawa. The network helps show where Mika Kitagawa may publish in the future.

Co-authorship network of co-authors of Mika Kitagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Kitagawa. A scholar is included among the top collaborators of Mika Kitagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Kitagawa. Mika Kitagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Okuda, Yusuke, Takaya Shimura, Yuichi Abe, et al.. (2024). Urinary dipeptidase 1 and trefoil factor 1 are promising biomarkers for early diagnosis of colorectal cancer. Journal of Gastroenterology. 59(7). 572–585.

Mori, Yoshinori, Hideki Maeda, Mika Kitagawa, et al.. (2023). BRAF V600E-mutated Colorectal Neuroendocrine Carcinoma Effectively Treated with a Chemotherapy Protocol for BRAF-mutated Metastatic Colorectal Cancer. Internal Medicine. 63(14). 1995–1999.

Shimura, Takaya, Hiroyasu Iwasaki, Takahito Katano, et al.. (2023). A prospective cohort study of a new electrosurgical unit for preventing colorectal post‐endoscopic submucosal dissection coagulation syndrome. Journal of Gastroenterology and Hepatology. 39(3). 473–479. 1 indexed citations

Fukusada, Shigeki, Takaya Shimura, Hiroyasu Iwasaki, et al.. (2021). Relationship between Immunophenotype and Clinicopathological Findings for Superficial Nonampullary Duodenal Epithelial Tumor. Digestion. 102(6). 870–877. 7 indexed citations

Okuda, Yusuke, Takaya Shimura, Hiroyasu Iwasaki, et al.. (2021). Urinary microRNA biomarkers for detecting the presence of esophageal cancer. Scientific Reports. 11(1). 8508–8508. 21 indexed citations

Fukusada, Shigeki, Takaya Shimura, Hiroyasu Iwasaki, et al.. (2021). Relationship between gene mutations and clinicopathological features in nonampullary duodenal epithelial tumors. Digestive and Liver Disease. 54(7). 905–910. 1 indexed citations

Iwasaki, Hiroyasu, Takaya Shimura, Tomonori Yamada, et al.. (2021). Novel and Simple Criteria for Predicting Mortality of Peptic Ulcer Disease. Internal Medicine. 60(15). 2349–2356. 2 indexed citations

Tanida, Satoshi, Keiji Ozeki, Tsutomu Mizoshita, et al.. (2020). Combination Therapy With Tofacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis as Induction Therapy for Refractory Ulcerative Colitis. Journal of Clinical Medicine Research. 12(1). 36–40. 8 indexed citations

Shimura, Takaya, Delphine Daydé, Hong Wang, et al.. (2020). Novel urinary protein biomarker panel for early diagnosis of gastric cancer. British Journal of Cancer. 123(11). 1656–1664. 45 indexed citations

10.

Okuda, Yusuke, Takaya Shimura, Hiroyasu Iwasaki, et al.. (2020). Serum Exosomal Dicer Is a Useful Biomarker for Early Detection of Differentiated Gastric Adenocarcinoma. Digestion. 102(4). 640–649. 7 indexed citations

11.

Iwasaki, Hiroyasu, Takaya Shimura, Tamaki Yamada, et al.. (2019). A novel urinary microRNA biomarker panel for detecting gastric cancer. Journal of Gastroenterology. 54(12). 1061–1069. 46 indexed citations

12.

Shimura, Takaya, Hiroyasu Iwasaki, Mika Kitagawa, et al.. (2019). Urinary Cysteine-Rich Protein 61 and Trefoil Factor 3 as Diagnostic Biomarkers for Colorectal Cancer. Translational Oncology. 12(3). 539–544. 20 indexed citations

13.

Natsume, Makoto, Takaya Shimura, Hiroyasu Iwasaki, et al.. (2019). Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 83(6). 1037–1046. 10 indexed citations

14.

Nishie, Hirotada, Hiromi Kataoka, Hiroyuki Kato, et al.. (2018). Refractory gastric antral ulcers without Helicobacter pylori infection and non-steroidal anti-inflammatory drugs. Clinical Journal of Gastroenterology. 11(3). 251–256. 1 indexed citations

15.

Kataoka, Hiromi, Yoshinori Mori, Takaya Shimura, et al.. (2016). A phase II prospective study of the trastuzumab combined with 5-weekly S-1 and CDDP therapy for HER2-positive advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 77(5). 957–962. 16 indexed citations

16.

Ebi, Masahide, Takaya Shimura, Tomonori Yamada, et al.. (2015). Multicenter, prospective trial of white-light imaging alone versus white-light imaging followed by magnifying endoscopy with narrow-band imaging for the real-time imaging and diagnosis of invasion depth in superficial esophageal squamous cell carcinoma. Gastrointestinal Endoscopy. 81(6). 1355–1361.e2. 46 indexed citations

17.

Shimura, Takaya, Mika Kitagawa, Tomonori Yamada, et al.. (2012). The Impact of Cross-Resistance Between Paclitaxel and Docetaxel for Metastatic Gastric Cancer. Onkologie. 35(4). 176–183. 6 indexed citations

18.

Shimura, Takaya, Mika Kitagawa, Tomonori Yamada, et al.. (2012). C-reactive protein is a potential prognostic factor for metastatic gastric cancer.. PubMed. 32(2). 491–6. 30 indexed citations

19.

Tsujimoto, M, et al.. (1993). Further study of nebulisation chemotherapy, a new chemotherapeutic method in the treatment of lung carcinomas: fundamental and clinical. British Journal of Cancer. 68(6). 1146–1149. 95 indexed citations

20.

Tsujimoto, M, Shohei Koyama, Harunobu Sato, et al.. (1990). 4, 6-0-Benzylidene-D-glucopyranose (BG) in the treatment of solid malignant tumours, an extended phase I study. British Journal of Cancer. 62(3). 436–439. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact